Lack of effect of sertraline on the pharmacokinetics of alprazolam. 2000

S H Preskorn, and D J Greenblatt, and A T Harvey

UI MeSH Term Description Entries
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000525 Alprazolam A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) Alprazolan,Alprox,Apo-Alpraz,Cassadan,D-65MT,Esparon,Kalma,Novo-Alprazol,Nu-Alpraz,Ralozam,Tafil,Trankimazin,U-31,889,Xanax,Apo Alpraz,D65MT,Novo Alprazol,Nu Alpraz,U31,889
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents
D018687 Antidepressive Agents, Second-Generation A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. Antidepressants, Atypical,Atypical Antidepressants,Second-Generation Antidepressive Agents,Antidepressive Drugs, Second-Generation,Agents, Second-Generation Antidepressive,Antidepressive Agents, Second Generation,Antidepressive Drugs, Second Generation,Drugs, Second-Generation Antidepressive,Second Generation Antidepressive Agents,Second-Generation Antidepressive Drugs
D019540 Area Under Curve A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992) AUC,Area Under Curves,Curve, Area Under,Curves, Area Under,Under Curve, Area,Under Curves, Area
D020280 Sertraline A selective serotonin uptake inhibitor that is used in the treatment of depression. Altruline,Apo-Sertraline,Aremis,Besitran,Gen-Sertraline,Gladem,Lustral,Novo-Sertraline,Rhoxal-sertraline,Sealdin,Sertraline Hydrochloride,Sertraline Hydrochloride (1S-cis)-Isomer,Zoloft,ratio-Sertraline,Apo Sertraline,Gen Sertraline,Hydrochloride, Sertraline,Novo Sertraline,Rhoxal sertraline,ratio Sertraline

Related Publications

S H Preskorn, and D J Greenblatt, and A T Harvey
February 1998, Psychopharmacology,
S H Preskorn, and D J Greenblatt, and A T Harvey
January 1998, Psychopharmacology bulletin,
S H Preskorn, and D J Greenblatt, and A T Harvey
April 2001, Journal of clinical pharmacology,
S H Preskorn, and D J Greenblatt, and A T Harvey
March 1989, Clinical pharmacokinetics,
S H Preskorn, and D J Greenblatt, and A T Harvey
May 1998, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
S H Preskorn, and D J Greenblatt, and A T Harvey
August 1997, Clinical pharmacology and therapeutics,
S H Preskorn, and D J Greenblatt, and A T Harvey
August 1983, The Journal of clinical psychiatry,
S H Preskorn, and D J Greenblatt, and A T Harvey
May 2005, Bosnian journal of basic medical sciences,
S H Preskorn, and D J Greenblatt, and A T Harvey
January 1996, The Journal of clinical psychiatry,
S H Preskorn, and D J Greenblatt, and A T Harvey
October 1998, Psychopharmacology,
Copied contents to your clipboard!